[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors",
    "summary": "In the latest trading session, Boston Scientific (BSX) closed at $104.50, marking a -0.01% move from the previous day.",
    "url": "https://finnhub.io/api/news?id=ed8622d652b95ca8ceedd4ee0da31abd0ed85a009066ce1431c462496294b6da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748556005,
      "headline": "Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors",
      "id": 134864069,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "In the latest trading session, Boston Scientific (BSX) closed at $104.50, marking a -0.01% move from the previous day.",
      "url": "https://finnhub.io/api/news?id=ed8622d652b95ca8ceedd4ee0da31abd0ed85a009066ce1431c462496294b6da"
    }
  },
  {
    "ts": null,
    "headline": "Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire",
    "summary": "Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.",
    "url": "https://finnhub.io/api/news?id=ab1bc3febefb61a1cc97cd4a442e907f1648037714c8f706bc64d26139116f4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748516433,
      "headline": "Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire",
      "id": 134812235,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.",
      "url": "https://finnhub.io/api/news?id=ab1bc3febefb61a1cc97cd4a442e907f1648037714c8f706bc64d26139116f4e"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific plans changes to expected $200M tariff hit as situation shifts",
    "summary": "The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.",
    "url": "https://finnhub.io/api/news?id=49f56dda3d1822242e3c5221a90983795067f3213664a21b34e348dbe6b5bdce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748500896,
      "headline": "Boston Scientific plans changes to expected $200M tariff hit as situation shifts",
      "id": 134907076,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.",
      "url": "https://finnhub.io/api/news?id=49f56dda3d1822242e3c5221a90983795067f3213664a21b34e348dbe6b5bdce"
    }
  }
]